Oculis raised €47M in a Series C round in May 2021. The company is based in Lausanne, Switzerland. Investors in the round: Bay City Capital, Brunnur Ventures, BVCF Management and 9 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
